These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 31784650)

  • 21. CRISPR-Barcoding for Intratumor Genetic Heterogeneity Modeling and Functional Analysis of Oncogenic Driver Mutations.
    Guernet A; Mungamuri SK; Cartier D; Sachidanandam R; Jayaprakash A; Adriouch S; Vezain M; Charbonnier F; Rohkin G; Coutant S; Yao S; Ainani H; Alexandre D; Tournier I; Boyer O; Aaronson SA; Anouar Y; Grumolato L
    Mol Cell; 2016 Aug; 63(3):526-38. PubMed ID: 27453044
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cancer heterogeneity: converting a limitation into a source of biologic information.
    Rübben A; Araujo A
    J Transl Med; 2017 Sep; 15(1):190. PubMed ID: 28886708
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Simulation framework for generating intratumor heterogeneity patterns in a cancer cell population.
    Iwasaki WM; Innan H
    PLoS One; 2017; 12(9):e0184229. PubMed ID: 28877206
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Variability in the Solid Cancer Cell Population and Its Consequences for Cancer Diagnostics and Treatment.
    Brychtová V; Valík V; Vojtěšek B
    Klin Onkol; 2018; 31(Suppl 2):5-13. PubMed ID: 31023018
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future.
    McGranahan N; Swanton C
    Cell; 2017 Feb; 168(4):613-628. PubMed ID: 28187284
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Breast cancer intratumor genetic heterogeneity: causes and implications.
    Ng CK; Pemberton HN; Reis-Filho JS
    Expert Rev Anticancer Ther; 2012 Aug; 12(8):1021-32. PubMed ID: 23030222
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical implications of intratumor heterogeneity: challenges and opportunities.
    Ramón Y Cajal S; Sesé M; Capdevila C; Aasen T; De Mattos-Arruda L; Diaz-Cano SJ; Hernández-Losa J; Castellví J
    J Mol Med (Berl); 2020 Feb; 98(2):161-177. PubMed ID: 31970428
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Deciphering intratumor heterogeneity using cancer genome analysis.
    Ryu D; Joung JG; Kim NK; Kim KT; Park WY
    Hum Genet; 2016 Jun; 135(6):635-42. PubMed ID: 27126234
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intratumor genetic heterogeneity in advanced human colorectal adenocarcinoma.
    Baisse B; Bouzourene H; Saraga EP; Bosman FT; Benhattar J
    Int J Cancer; 2001 Aug; 93(3):346-52. PubMed ID: 11433398
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A system for detecting high impact-low frequency mutations in primary tumors and metastases.
    Anjanappa M; Hao Y; Simpson ER; Bhat-Nakshatri P; Nelson JB; Tersey SA; Mirmira RG; Cohen-Gadol AA; Saadatzadeh MR; Li L; Fang F; Nephew KP; Miller KD; Liu Y; Nakshatri H
    Oncogene; 2018 Jan; 37(2):185-196. PubMed ID: 28892047
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of Mutation Density and Heterogeneity on Papillary Thyroid Cancer Clinical Features and Remission Probability.
    Colombo C; Muzza M; Proverbio MC; Tosi D; Soranna D; Pesenti C; Rossi S; Cirello V; De Leo S; Fusco N; Miozzo M; Bulfamante G; Vicentini L; Ferrero S; Zambon A; Tabano S; Fugazzola L
    Thyroid; 2019 Feb; 29(2):237-251. PubMed ID: 30501571
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intra-tumor heterogeneity from a cancer stem cell perspective.
    Prasetyanti PR; Medema JP
    Mol Cancer; 2017 Feb; 16(1):41. PubMed ID: 28209166
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intratumor heterogeneity: nature and biological significance.
    Gerashchenko TS; Denisov EV; Litviakov NV; Zavyalova MV; Vtorushin SV; Tsyganov MM; Perelmuter VM; Cherdyntseva NV
    Biochemistry (Mosc); 2013 Nov; 78(11):1201-15. PubMed ID: 24460935
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Measuring Clonal Evolution in Cancer with Genomics.
    Williams MJ; Sottoriva A; Graham TA
    Annu Rev Genomics Hum Genet; 2019 Aug; 20():309-329. PubMed ID: 31059289
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypoxia-driven intratumor heterogeneity and immune evasion.
    Terry S; Engelsen AST; Buart S; Elsayed WS; Venkatesh GH; Chouaib S
    Cancer Lett; 2020 Nov; 492():1-10. PubMed ID: 32712233
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intratumor heterogeneity in evolutionary models of tumor progression.
    Durrett R; Foo J; Leder K; Mayberry J; Michor F
    Genetics; 2011 Jun; 188(2):461-77. PubMed ID: 21406679
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Practical Approach to Tumor Heterogeneity in Clinical Research and Diagnostics.
    Stanta G; Bonin S
    Pathobiology; 2018; 85(1-2):7-17. PubMed ID: 28750401
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The impact of tumor epithelial and microenvironmental heterogeneity on treatment responses in HER2+ breast cancer.
    Janiszewska M; Stein S; Metzger Filho O; Eng J; Kingston NL; Harper NW; Rye IH; Alečković M; Trinh A; Murphy KC; Marangoni E; Cristea S; Oakes B; Winer EP; Krop IE; Russnes HG; Spellman PT; Bucher E; Hu Z; Chin K; Gray JW; Michor F; Polyak K
    JCI Insight; 2021 Jun; 6(11):. PubMed ID: 33886505
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evolutionary dynamics of intratumor heterogeneity.
    Iwasa Y; Michor F
    PLoS One; 2011 Mar; 6(3):e17866. PubMed ID: 21479218
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of the Immune Component of Tumor Microenvironment in the Efficiency of Cancer Treatment: Perspectives for the Personalized Therapy.
    Stakheyeva M; Riabov V; Mitrofanova I; Litviakov N; Choynzonov E; Cherdyntseva N; Kzhyshkowska J
    Curr Pharm Des; 2017; 23(32):4807-4826. PubMed ID: 28714406
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.